In this project we propose to study the biochemical changes 2, 3, 4, 7, 8-TCDD (tetrachlorodibenzo-p-dioxin) and related chlorinated aromatics cause in experimental animals. The major emphasis will be placed on their effects on plasma membrane-bound enzymes and receptors. Preliminary experiments have revealed that the hepatic plasma membrane from TCDD-treated rats in vivo has unusually low levels of various ATPases, binding capabilities towards concanavalin A, insulin and low density lipoprotein. As a result there is a possibility that many biochemical lesions which are observed in TCDD-treated animals such as body weight loss, thymic involution, reduction in cell-mediated immune response and tumor promotion may be explained on the basis of the changes in the function of the cell surface membrane. Specific projects proposed are: (1) Studies on the relationship between TCDD-induced changes in the hepatic plasma membrane functions and hepatotoxicity and carcinogenicity, (2) interspecific differences in susceptibility of the hepatic plasma membrane functions toward TCDD treatment in vivo, (3) TCDD effects on lipoprotein regulation in the guinea pig liver, (4) the changes induced in the plasma membrane from the adipose tissues of the guinea pig by TCDD treatment, (5) effects of reduced lipoprotein-receptor interaction on extra-hepatic functions, and (6) studies on increased protein kinase activities as the cause for pleiotropic alteration of plasma membrane receptors and enzymes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003575-05
Application #
3250989
Study Section
(SSS)
Project Start
1987-12-01
Project End
1989-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
Earth Sciences/Resources
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Hwang, Seong Gu; Sasagawa, Hiromi; Matsumura, Fumio (2007) Effect of in vitro administered 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on DNA-binding activities of nuclear transcription factors in NIH-3T3 mouse fibroblasts. J Environ Sci Health B 42:115-23
Liu, Phillip C C; Moreno-Aliaga, Maria J; Dunlap, Debra Y et al. (2002) Correlation between the high expression of C/EBPbeta protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3-L1 cells. J Biochem Mol Toxicol 16:70-83
Moreno-Aliaga, Maria J; Matsumura, Fumio (2002) Effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p,p'-DDT) on 3T3-L1 and 3T3-F442A adipocyte differentiation. Biochem Pharmacol 63:997-1007
Nagashima, Hitoshi; Matsumura, Fumio (2002) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced down-regulation of glucose transporting activities in mouse 3T3-L1 preadipocyte. J Environ Sci Health B 37:1-14
Dunlap, D Y; Matsumura, F (2000) Analysis of difference in vivo effects of TCDD between c-src +/+ mice, c-src deficient, -/+ and -/- B6, 129-Src(tm 1 sor) mice and their wild-type littermates. Chemosphere 40:1241-6
Datta, S; Ohyama, K; Dunlap, D Y et al. (1999) Evidence for organochlorine contamination in tissues of salmonids in Lake Tahoe. Ecotoxicol Environ Saf 42:94-101
Moreno-Aliaga, M J; Matsumura, F (1999) Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells. Mol Pharmacol 56:91-101
Enan, E; Dunlap, D Y; Matsumura, F (1998) Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signaling in the expression of toxicity of TCDD. J Biochem Mol Toxicol 12:263-74
Enan, E; Matsumura, F (1998) Activation of c-Neu tyrosine kinase by o,p'-DDT and beta-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells. J Biochem Mol Toxicol 12:83-92
Liu, P C; Dunlap, D Y; Matsumura, F (1998) Suppression of C/EBPalpha and induction of C/EBPbeta by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse adipose tissue and liver. Biochem Pharmacol 55:1647-55

Showing the most recent 10 out of 45 publications